Annual report

Period2021-12-01 → 2022-11-30
Filed2023-02-24
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
MetricValuePeriodScopeSource row
Revenue¥8.4bn2021-12-01 → 2022-11-30Cons.Net sales
Revenue¥7.9bn2020-12-01 → 2021-11-30Cons.Net sales
Revenue¥6.6bn2019-12-01 → 2020-11-30dCons.Net sales (5-year summary)
Revenue¥7.5bn2018-12-01 → 2019-11-30dCons.Net sales (5-year summary)
Revenue¥7.6bn2017-12-01 → 2018-11-30dCons.Net sales (5-year summary)
Operating income¥294m2021-12-01 → 2022-11-30Cons.Operating income
Operating income¥381m2020-12-01 → 2021-11-30Cons.Operating income
Ordinary income¥303m2021-12-01 → 2022-11-30Cons.Ordinary income
Ordinary income¥386m2020-12-01 → 2021-11-30Cons.Ordinary income
Ordinary income¥83m2019-12-01 → 2020-11-30dCons.Ordinary income loss (5-year summary)
Ordinary income¥187m2018-12-01 → 2019-11-30dCons.Ordinary income loss (5-year summary)
Ordinary income¥240m2017-12-01 → 2018-11-30dCons.Ordinary income loss (5-year summary)
Profit before tax¥283m2021-12-01 → 2022-11-30Cons.Income before income taxes
Profit before tax¥394m2020-12-01 → 2021-11-30Cons.Income before income taxes
Net income (owners)¥219m2021-12-01 → 2022-11-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥281m2020-12-01 → 2021-11-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥59m2019-12-01 → 2020-11-30dCons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥147m2018-12-01 → 2019-11-30dCons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥168m2017-12-01 → 2018-11-30dCons.Profit loss attributable to owners of parent (5-year summary)
Net income¥219m2021-12-01 → 2022-11-30Cons.Profit loss
Net income¥281m2020-12-01 → 2021-11-30Cons.Profit loss
Total assets¥8.3bnat 2022-11-30Cons.Assets
Total assets¥7.9bnat 2021-11-30Cons.Assets
Total assets¥7.2bnat 2020-11-30dCons.Total assets (5-year summary)
Total assets¥7.3bnat 2019-11-30dCons.Total assets (5-year summary)
Total assets¥6.8bnat 2018-11-30dCons.Total assets (5-year summary)
Total liabilities¥5.9bnat 2022-11-30Cons.Liabilities
Total liabilities¥5.6bnat 2021-11-30Cons.Liabilities
Net assets / equity¥2.4bnat 2022-11-30Cons.Net assets
Net assets / equity¥2.3bnat 2021-11-30Cons.Net assets
Net assets / equity¥2.0bnat 2020-11-30dCons.Net assets
Net assets / equity¥1.9bnat 2019-11-30dCons.Net assets (5-year summary)
Net assets / equity¥1.8bnat 2018-11-30dCons.Net assets (5-year summary)
Cash and deposits¥911mat 2022-11-30Cons.Cash and deposits
Cash and deposits¥1.3bnat 2021-11-30Cons.Cash and deposits
Cash & equivalents¥911mat 2022-11-30Cons.Cash and cash equivalents
Cash & equivalents¥1.3bnat 2021-11-30Cons.Cash and cash equivalents
Cash & equivalents¥883mat 2020-11-30dCons.Cash and cash equivalents
Cash & equivalents¥397mat 2019-11-30dCons.Cash and cash equivalents (5-year summary)
Cash & equivalents¥675mat 2018-11-30dCons.Cash and cash equivalents (5-year summary)
Operating cash flow−¥21m2021-12-01 → 2022-11-30Cons.Net cash provided by used in operating activities
Operating cash flow¥785m2020-12-01 → 2021-11-30Cons.Net cash provided by used in operating activities
Operating cash flow¥654m2019-12-01 → 2020-11-30dCons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥286m2018-12-01 → 2019-11-30dCons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥162m2017-12-01 → 2018-11-30dCons.Net cash provided by used in operating activities (5-year summary)
Investing cash flow−¥243m2021-12-01 → 2022-11-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥246m2020-12-01 → 2021-11-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥392m2019-12-01 → 2020-11-30dCons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥907m2018-12-01 → 2019-11-30dCons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥629m2017-12-01 → 2018-11-30dCons.Net cash provided by used in investing activities (5-year summary)
Financing cash flow−¥162m2021-12-01 → 2022-11-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥119m2020-12-01 → 2021-11-30Cons.Net cash provided by used in financing activities
Financing cash flow¥222m2019-12-01 → 2020-11-30dCons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥349m2018-12-01 → 2019-11-30dCons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥301m2017-12-01 → 2018-11-30dCons.Net cash provided by used in financing activities (5-year summary)
EPS (basic)¥179.752021-12-01 → 2022-11-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥230.992020-12-01 → 2021-11-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥48.732019-12-01 → 2020-11-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥120.482018-12-01 → 2019-11-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥137.912017-12-01 → 2018-11-30dCons.Basic earnings loss per share (5-year summary)
Net assets per share¥1,980.62at 2022-11-30Cons.Net assets per share (5-year summary)
Net assets per share¥1,850.07at 2021-11-30Cons.Net assets per share (5-year summary)
Net assets per share¥1,619.73at 2020-11-30dCons.Net assets per share (5-year summary)
Net assets per share¥1,600.24at 2019-11-30dCons.Net assets per share (5-year summary)
Net assets per share¥1,516.9at 2018-11-30dCons.Net assets per share (5-year summary)
Equity ratio29.0%at 2022-11-30Cons.Equity to asset ratio (5-year summary)
Equity ratio28.5%at 2021-11-30Cons.Equity to asset ratio (5-year summary)
Equity ratio27.4%at 2020-11-30dCons.Equity to asset ratio (5-year summary)
Equity ratio26.7%at 2019-11-30dCons.Equity to asset ratio (5-year summary)
Equity ratio27.2%at 2018-11-30dCons.Equity to asset ratio (5-year summary)
ROE9.4%2021-12-01 → 2022-11-30Cons.Rate of return on equity (5-year summary)
ROE13.3%2020-12-01 → 2021-11-30Cons.Rate of return on equity (5-year summary)
ROE3.0%2019-12-01 → 2020-11-30dCons.Rate of return on equity (5-year summary)
ROE7.7%2018-12-01 → 2019-11-30dCons.Rate of return on equity (5-year summary)
ROE9.4%2017-12-01 → 2018-11-30dCons.Rate of return on equity (5-year summary)
Employees171at 2022-11-30Cons.Number of employees
Employees165at 2021-11-30Cons.Number of employees
Employees173at 2020-11-30dCons.Number of employees
Employees164at 2019-11-30dCons.Number of employees
Employees163at 2018-11-30dCons.Number of employees
Revenue¥8.2bn2021-12-01 → 2022-11-30StandaloneNet sales
Revenue¥7.7bn2020-12-01 → 2021-11-30StandaloneNet sales
Revenue¥6.5bn2019-12-01 → 2020-11-30dStandaloneNet sales (5-year summary)
Revenue¥7.4bn2018-12-01 → 2019-11-30dStandaloneNet sales (5-year summary)
Revenue¥7.5bn2017-12-01 → 2018-11-30dStandaloneNet sales (5-year summary)
Operating income¥249m2021-12-01 → 2022-11-30StandaloneOperating income
Operating income¥318m2020-12-01 → 2021-11-30StandaloneOperating income
Ordinary income¥262m2021-12-01 → 2022-11-30StandaloneOrdinary income
Ordinary income¥329m2020-12-01 → 2021-11-30StandaloneOrdinary income
Ordinary income¥59m2019-12-01 → 2020-11-30dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥162m2018-12-01 → 2019-11-30dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥199m2017-12-01 → 2018-11-30dStandaloneOrdinary income loss (5-year summary)
Profit before tax¥243m2021-12-01 → 2022-11-30StandaloneIncome before income taxes
Profit before tax¥337m2020-12-01 → 2021-11-30StandaloneIncome before income taxes
Net income¥185m2021-12-01 → 2022-11-30StandaloneProfit loss
Net income¥242m2020-12-01 → 2021-11-30StandaloneProfit loss
Net income¥40m2019-12-01 → 2020-11-30dStandaloneNet income loss (5-year summary)
Net income¥128m2018-12-01 → 2019-11-30dStandaloneNet income loss (5-year summary)
Net income¥129m2017-12-01 → 2018-11-30dStandaloneNet income loss (5-year summary)
Total assets¥8.2bnat 2022-11-30StandaloneAssets
Total assets¥7.8bnat 2021-11-30StandaloneAssets
Total assets¥7.1bnat 2020-11-30dStandaloneTotal assets (5-year summary)
Total assets¥7.2bnat 2019-11-30dStandaloneTotal assets (5-year summary)
Total assets¥6.8bnat 2018-11-30dStandaloneTotal assets (5-year summary)
Total liabilities¥5.9bnat 2022-11-30StandaloneLiabilities
Total liabilities¥5.6bnat 2021-11-30StandaloneLiabilities
Net assets / equity¥2.2bnat 2022-11-30StandaloneNet assets
Net assets / equity¥2.1bnat 2021-11-30StandaloneNet assets
Net assets / equity¥1.9bnat 2020-11-30dStandaloneNet assets
Net assets / equity¥1.9bnat 2019-11-30dStandaloneNet assets (5-year summary)
Net assets / equity¥1.8bnat 2018-11-30dStandaloneNet assets (5-year summary)
Cash and deposits¥683mat 2022-11-30StandaloneCash and deposits
Cash and deposits¥1.1bnat 2021-11-30StandaloneCash and deposits
EPS (basic)¥151.852021-12-01 → 2022-11-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥198.642020-12-01 → 2021-11-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥32.472019-12-01 → 2020-11-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥104.92018-12-01 → 2019-11-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥105.992017-12-01 → 2018-11-30dStandaloneBasic earnings loss per share (5-year summary)
Dividend per share¥502021-12-01 → 2022-11-30StandaloneDividend paid per share (5-year summary)
Dividend per share¥502020-12-01 → 2021-11-30StandaloneDividend paid per share (5-year summary)
Dividend per share¥302019-12-01 → 2020-11-30dStandaloneDividend paid per share (5-year summary)
Dividend per share¥302018-12-01 → 2019-11-30dStandaloneDividend paid per share (5-year summary)
Dividend per share¥302017-12-01 → 2018-11-30dStandaloneDividend paid per share (5-year summary)
Net assets per share¥1,847.66at 2022-11-30StandaloneNet assets per share (5-year summary)
Net assets per share¥1,758.24at 2021-11-30StandaloneNet assets per share (5-year summary)
Net assets per share¥1,573.45at 2020-11-30dStandaloneNet assets per share (5-year summary)
Net assets per share¥1,571.92at 2019-11-30dStandaloneNet assets per share (5-year summary)
Net assets per share¥1,500.32at 2018-11-30dStandaloneNet assets per share (5-year summary)
Equity ratio27.6%at 2022-11-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio27.6%at 2021-11-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio26.9%at 2020-11-30dStandaloneEquity to asset ratio (5-year summary)
Equity ratio26.4%at 2019-11-30dStandaloneEquity to asset ratio (5-year summary)
Equity ratio27.1%at 2018-11-30dStandaloneEquity to asset ratio (5-year summary)
ROE8.4%2021-12-01 → 2022-11-30StandaloneRate of return on equity (5-year summary)
ROE11.9%2020-12-01 → 2021-11-30StandaloneRate of return on equity (5-year summary)
ROE2.1%2019-12-01 → 2020-11-30dStandaloneRate of return on equity (5-year summary)
ROE6.8%2018-12-01 → 2019-11-30dStandaloneRate of return on equity (5-year summary)
ROE7.2%2017-12-01 → 2018-11-30dStandaloneRate of return on equity (5-year summary)
Shares issued1,220,000at 2022-11-30StandaloneTotal number of issued shares (5-year summary)
Shares issued1,220,000at 2021-11-30StandaloneTotal number of issued shares (5-year summary)
Shares issued1,220,000at 2020-11-30dStandaloneTotal number of issued shares (5-year summary)
Shares issued1,220,000at 2019-11-30dStandaloneTotal number of issued shares (5-year summary)
Shares issued1,220,000at 2018-11-30dStandaloneTotal number of issued shares (5-year summary)
Employees166at 2022-11-30StandaloneNumber of employees
Employees159at 2021-11-30StandaloneNumber of employees
Employees167at 2020-11-30dStandaloneNumber of employees
Employees159at 2019-11-30dStandaloneNumber of employees
Employees159at 2018-11-30dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 36
SegmentItemPeriodValue
Pharmaceutical Productsreportable segmentcapex2021-12-01 → 2022-11-30¥382m
Pharmaceutical Productsreportable segmentdepreciation2021-12-01 → 2022-11-30¥396m
Pharmaceutical Productsreportable segmentemployeesat 2022-11-30170 pure
Pharmaceutical Productsreportable segmentrevenue2021-12-01 → 2022-11-30¥8.3bn
Pharmaceutical Productsreportable segmentrevenue external2021-12-01 → 2022-11-30¥8.3bn
Pharmaceutical Productsreportable segmentsegment assetsat 2022-11-30¥8.3bn
Pharmaceutical Productsreportable segmentsegment profit2021-12-01 → 2022-11-30¥263m
Real Estate Leasingreportable segmentemployeesat 2022-11-301 pure
Real Estate Leasingreportable segmentrevenue2021-12-01 → 2022-11-30¥38m
Real Estate Leasingreportable segmentrevenue external2021-12-01 → 2022-11-30¥38m
Real Estate Leasingreportable segmentsegment assetsat 2022-11-30¥71m
Real Estate Leasingreportable segmentsegment profit2021-12-01 → 2022-11-30¥30m
Total Of Reportable Segments And Otherssegment totalcapex2021-12-01 → 2022-11-30¥382m
Total Of Reportable Segments And Otherssegment totaldepreciation2021-12-01 → 2022-11-30¥396m
Total Of Reportable Segments And Otherssegment totalrevenue2021-12-01 → 2022-11-30¥8.4bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-12-01 → 2022-11-30¥8.4bn
Total Of Reportable Segments And Otherssegment totalsegment assetsat 2022-11-30¥8.3bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-12-01 → 2022-11-30¥294m
Pharmaceutical Productsreportable segmentcapex2020-12-01 → 2021-11-30¥262m
Pharmaceutical Productsreportable segmentdepreciation2020-12-01 → 2021-11-30¥378m
Pharmaceutical Productsreportable segmentrevenue2020-12-01 → 2021-11-30¥7.9bn
Pharmaceutical Productsreportable segmentrevenue external2020-12-01 → 2021-11-30¥7.9bn
Pharmaceutical Productsreportable segmentsegment assetsat 2021-11-30¥7.8bn
Pharmaceutical Productsreportable segmentsegment profit2020-12-01 → 2021-11-30¥350m
Real Estate Leasingreportable segmentrevenue2020-12-01 → 2021-11-30¥38m
Real Estate Leasingreportable segmentrevenue external2020-12-01 → 2021-11-30¥38m
Real Estate Leasingreportable segmentsegment assetsat 2021-11-30¥71m
Real Estate Leasingreportable segmentsegment profit2020-12-01 → 2021-11-30¥30m
Total Of Reportable Segments And Otherssegment totalcapex2020-12-01 → 2021-11-30¥262m
Total Of Reportable Segments And Otherssegment totaldepreciation2020-12-01 → 2021-11-30¥378m
Total Of Reportable Segments And Otherssegment totalrevenue2020-12-01 → 2021-11-30¥7.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2020-12-01 → 2021-11-30¥7.9bn
Total Of Reportable Segments And Otherssegment totalsegment assetsat 2021-11-30¥7.9bn
Total Of Reportable Segments And Otherssegment totalsegment profit2020-12-01 → 2021-11-30¥381m
Pharmaceutical Productsreportable segmentemployeesat 2022-11-30165 pure
Real Estate Leasingreportable segmentemployeesat 2022-11-301 pure

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,465
ItemContextValueUnit
Loss on retirement of noncurrent assets elPrior1YearDuration2911000JPY
Loss on retirement of noncurrent assets elCurrentYearDuration19338000JPY
Extraordinary lossPrior1YearDuration2911000JPY
Extraordinary lossCurrentYearDuration19338000JPY
Income before income taxesPrior1YearDuration393923000JPY
Income before income taxesCurrentYearDuration283474000JPY
Income taxes currentPrior1YearDuration91455000JPY
Income taxes currentCurrentYearDuration63804000JPY
Income taxes deferredPrior1YearDuration21193000JPY
Income taxes deferredCurrentYearDuration812000JPY
Income taxesPrior1YearDuration112649000JPY
Income taxesCurrentYearDuration64617000JPY
Profit lossPrior1YearDuration281274000JPY
Profit lossCurrentYearDuration218856000JPY
Profit loss attributable to non controlling interestsPrior1YearDuration-JPY
Profit loss attributable to non controlling interestsCurrentYearDuration-JPY
Profit loss attributable to owners of parentPrior1YearDuration281274000JPY
Profit loss attributable to owners of parentCurrentYearDuration218856000JPY
Profit lossPrior1YearDuration281274000JPY
Profit lossCurrentYearDuration218856000JPY
Valuation difference on available for sale securities net of tax ociPrior1YearDuration19620000JPY
Valuation difference on available for sale securities net of tax ociCurrentYearDuration-15180000JPY
Foreign currency translation adjustment net of tax ociPrior1YearDuration16052000JPY
Foreign currency translation adjustment net of tax ociCurrentYearDuration16107000JPY
Other comprehensive incomePrior1YearDuration35672000JPY
Other comprehensive incomeCurrentYearDuration927000JPY
Comprehensive incomePrior1YearDuration316946000JPY
Comprehensive incomeCurrentYearDuration219784000JPY
Comprehensive income attributable to owners of the parentPrior1YearDuration316946000JPY
Comprehensive income attributable to owners of the parentCurrentYearDuration219784000JPY
Comprehensive income attributable to non controlling interestsPrior1YearDuration-JPY
Comprehensive income attributable to non controlling interestsCurrentYearDuration-JPY
Net assetsPrior2YearInstant_CapitalStockMember610000000JPY
Net assetsPrior2YearInstant_CapitalSurplusMember58437000JPY
Net assetsPrior2YearInstant_RetainedEarningsMember1283724000JPY
Net assetsPrior2YearInstant_TreasuryStockMember-7749000JPY
Net assetsPrior2YearInstant_ShareholdersEquityMember1944413000JPY
Dividends from surplusPrior1YearDuration_RetainedEarningsMember-36533000JPY
Dividends from surplusPrior1YearDuration_ShareholdersEquityMember-36533000JPY
Profit loss attributable to owners of parentPrior1YearDuration_RetainedEarningsMember281274000JPY
Profit loss attributable to owners of parentPrior1YearDuration_ShareholdersEquityMember281274000JPY
Purchase of treasury stockPrior1YearDuration_TreasuryStockMember-318000JPY
Purchase of treasury stockPrior1YearDuration_ShareholdersEquityMember-318000JPY
Total changes of items during the periodPrior1YearDuration_CapitalStockMember-JPY
Total changes of items during the periodPrior1YearDuration_CapitalSurplusMember-JPY
Total changes of items during the periodPrior1YearDuration_RetainedEarningsMember244740000JPY
Total changes of items during the periodPrior1YearDuration_TreasuryStockMember-318000JPY
Total changes of items during the periodPrior1YearDuration_ShareholdersEquityMember244422000JPY
Net assetsPrior1YearInstant_CapitalStockMember610000000JPY
Net assetsPrior1YearInstant_CapitalSurplusMember58437000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 24 of 24 passed
balance sheet identityconsolidated 2021-11-30pass
balance sheet identityconsolidated 2022-11-30pass
balance sheet identitynon_consolidated 2021-11-30pass rounding
balance sheet identitynon_consolidated 2022-11-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2020-11-30pass
statement vs summary · net assetsconsolidated 2021-11-30pass
statement vs summary · net assetsconsolidated 2022-11-30pass
statement vs summary · net assetsnon_consolidated 2020-11-30pass
statement vs summary · net assetsnon_consolidated 2021-11-30pass
statement vs summary · net assetsnon_consolidated 2022-11-30pass
statement vs summary · net income attributable to parentconsolidated 2020-12-01/2021-11-30pass
statement vs summary · net income attributable to parentconsolidated 2021-12-01/2022-11-30pass
statement vs summary · operating cash flowconsolidated 2020-12-01/2021-11-30pass
statement vs summary · operating cash flowconsolidated 2021-12-01/2022-11-30pass
statement vs summary · revenueconsolidated 2020-12-01/2021-11-30pass
statement vs summary · revenueconsolidated 2021-12-01/2022-11-30pass
statement vs summary · revenuenon_consolidated 2020-12-01/2021-11-30pass
statement vs summary · revenuenon_consolidated 2021-12-01/2022-11-30pass
statement vs summary · total assetsconsolidated 2021-11-30pass
statement vs summary · total assetsconsolidated 2022-11-30pass
statement vs summary · total assetsnon_consolidated 2021-11-30pass
statement vs summary · total assetsnon_consolidated 2022-11-30pass